STUDIES ON HERPETIC INFECTION IN MICE : IV. THE EFFECT OF SPECIFIC ANTIBODIES ON THE PROGRESSION OF THE VIRUS WITHIN THE NERVOUS SYSTEM OF YOUNG MICE by Evans, Charles A. et al.
STUDIES  ON HERPETIC INFECTION  IN MICE 
IV.  THE EFFECT OF SPECIFIC ANTIBODIES ON THE PROGRESSION OF THE VIRUS 
wi~m~ T~v. NF.RVOUS SYSTEM OF Yotr~C MIcv.*$ 
BY  CHARLES A.  EVANS,  M.D.§,  HOWARD  B.  SLAVIN, M.D., 
Am)  GEORGE  PACKER BERRY,  M.D. 
(From the Departments of Bacteriology and Medicine, The University of Rochester School 
of Medicine and Dentistry,  Rochester, New York) 
(Received for publication,  June 27, 1946) 
In previously reported studies (1-3)  it was found that in young mice the 
intranasal instillation of herpes virus (HF strain) was followed by the prompt 
invasion of the central nervous system (CNS) by way of all available neural 
routes.  Death  resulted regularly on  the  4th  or  5th  day after inoculation, 
Specific  antibodies, acquired as the result of an intraperitoneal injection of 
immune rabbit serum or by suckling an immune mother, protected young mice 
from herpetic infection of this sort.  In these experiments the antibodies were 
present in the mice at the time the virus was administered.  They presumably 
protected the mice by preventing the formation of peripheral foci of infection 
from which invasion of the CNS could occu~ 
In order to determine whether passively acquired antibodies can significantly 
influence the course of herpetic infection within the CNS  of mice, further in- 
vestigations have been carried out.  Disturbance of the "blood-brain barrier," 
which might affect the penetration of antibodies into the CNS, was avoided by 
the use of a peripheral site of inoculation.  Specific antiserum was injected at 
various intervals after introduction of the virus, before involvement of the ner- 
vous system became apparent.  When experimental herpetic infections induced 
in this manner are  treated by administering specific  antiserum prior  to the 
appearance of obvious signs of involvement of the nervous system, it is virtually 
impossible to be certain whether an efficacious result is due to the effect of anti- 
bodies at the peripheral focus or within the nervous system.  In experiments 
included in the present report, this difficulty has been circumvented by elimi- 
nating, by amputation, the peripheral focus as a complicating factor.  It was 
found that hyperimmune rabbit serum,'injected intraperitoneally, can retard, 
and in some cases can completely arrest, the progress of an established herpetic 
infection within the nervous system of mice. 
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Clinical trials of immune serum in the treatment of virus infections of the CNS 
have been limited almost exclusively to poliomyelitis.  The results have been  dis- 
couraging.  Poliomyelitis virus exerts a relatively weak antigenic stimulus in human 
infections (4).  As a :result, most of the experimental and clinical trials made with 
convalescent human serum have been carried out with serum that was probably of 
low neutralizing capacity.  Indeed, little is known on this score, for careful titrations 
of convalescent human serum have rarely been made because of the expense of titrat- 
ing serum in monkeys. 
Relatively few experimental studies of the effects of specific antibodies on estab- 
lished virus infections within the nervous system have been published.  True, there 
are reports of experiments in which specific antiserum was injected into animals that 
subsequently were inoculated with a  neurotropic virus.  Experiments of this type 
have  shown  that  specific antibodies given before the  inoculation of  the  virus are 
capable of preventing infection of the nervous system with the viruses of rabies (5), 
poliomyelitis (6), equine encephalomyelitis (7, 8), and herpes simplex (1, 9, 10).  Pre- 
sumably, in  these  experiments,  the  virus was  neutralized principally, or entirely, 
before nerve cells were infected.  While such experiments are informative in regard 
to the general question of immunity to neurotropic viruses, they shed little light on the 
relationship of antibodies to virus infections established within the nervous system. 
Experiments in which serum treatment has been delayed a period of hours or days 
after inoculation of virus have been reported with poliomyelitis (11-13), rabies (5, 
14), and equine encephalomyelitis (7, 8, 15-17). 
In the experiments of Schultz and Gebhardt on poliomyelitis (11), large numbers of 
monkeys were inoculated with the virus and, after an interval of from 1 to 6 days, the 
animals were treated with immune serum.  Although a few treated animals survived 
or underwent a prolonged course of the disease, they were so few in number that the 
authors  concluded,  "specific immune  serum  is without  demonstrable value in  the 
treatment of experimental poliomyelitis."  Kramer (12) has shown that mice infected 
with the Lansing strain of poliomyelitis virus by intracranial inoculation may be 
significantly benefited by treatment  with  immune  serum.  In one  experiment the 
results suggested a possible effect of serum as late as 96 hours, although serumhad no 
effect upon a group of 12 mice treated at 48 hours.  Howe and Bodian~(13) injected 3 
chimpanzees with large amounts of serum of known antipoliomyelitic activity and 
subsequently infected these 3 animals by the oral route.  Poliomyelitis  virus appeared 
in the feces.  Although no paralysis developed in these animals or in 3 control chim- 
panzees given virus but no serum, all 6 exhibited lesions of the nervous system con- 
sidered characteristic of poliomyelitis. 
Habel (14) has recently described experiments with rabies virus in which the quan- 
tRative aspects of passive immunization, and the time at which serum treatment may 
be effective, were carefully studied.  Using guinea pigs inoculated intramuscularly 
with the virus, he found that antiserum.injected at 3 hours protected 15 out of 19 
animals; if serum was given at 24 hours,  10 out of 19 guinea pigs survived.  With 
treatment at 48 and 72 hours, the number of survivors was smaller but possibly sig- 
nificant (4 out of 10, and 2 out of 9).  In mice a 25 per cent survival rate was obtained 
with treatment at 24 hours; 3 of 24 animals treated at 48 hours survived.  It is not 
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system, although this  is  suggested by the fact that  animals  that  succumbed  after 
serum treatment usually died several days later than untreated mice. 
Wyckoff and Tesar  (16), working with young rhesus monkeys infected by the nasal 
route with Eastern or Western equine encephalomyelitis virus, found hyperimmune 
horse  serum  to  be  of  no  value  if  given  after  the  appearance  of  fever.  Zichis 
and Shaughnessy (7) have attributed these unfavorable results to the use of insufficient 
.quantities of antiserum. 
Zichis and Shaughnessy (15) have reported a study in which hyperimmune rabbit 
serum was used therapeutically in the early stages of infection with Western equine 
encephalomyelitis virus.  Mice were inoculated intracerebraUy and guinea pigs intra- 
lingually with  known  quantities  of the  virus.  The serum  was injected  intraperi- 
toneally into the mice either 48 hours after infection or later, at a time when they 
showed signs of illness.  Guinea pigs were given the serum either at the onset of fever 
or at a  time when they were visibly ill.  The authors stated,  "The majority of the 
animals treated at these stages of the disease  recovered, whereas all the  untreated 
controls died."  Challenge inoculations of equine encephalomyelitis virus adminis- 
tered to survivors showed that the mice injected with serum at 48 hours, and the guinea 
pigs injected at the onset of fever, were not immune, but that the mice and guinea pigs 
that had recovered after treatment,  begun when the animals were visibly sick, p0  s- 
sessed an active immunity.  The results of these experiments indicate a much greater 
therapeutic  effect than has been found in the treatment  of other virus diseases  of 
the CNS. 
Olitsky, Schlesinger,  and Morgan (8), when they injected the Zichis strain of equine 
encephalomyelitis virus intracerebraUy into mice, found that  immune serum given 
subcutaneously to infected mice at the onset of illness  (3 to 5 days) failed to protect. 
In a similar experiment, using the Rockefeller strain of virus which brings on illness 
more rapidly, they found that the immune serum had no therapeutic action when given 
to mice at 48 hours and little or no effect at 24 hours.  When, however, antiserum 
was given 24 or 48 hours after the inoculation of the foot pad of guinea pigs with the 
virus of equine encephalomyelitis, the animals survived or developed delayed reac- 
tions terminating in death.  Antiserum given at 72 or 96 hours was ineffective.  How 
much of the beneficial effect resulted from neutralization of the virus in the foot pad 
or elsewhere outside the nervous system, and how much from an action upon the virus 
within the nervous system, is unknown.  The surviving animals were not actively 
immune. 
In studying immunity to equine encephalomyelitis in rabbits, Schlesinger, Morgan, 
and Olitsky  (19)  found that vaccinated animals were resistant  to an intracerebral 
injection of the virus only if their serums contained sttfficient  antibody to give a titer 
of 1:300 or higher.  Subcutaneous injection of the virus usually gave rise to inap- 
parent infection of the CNS which most of the animals survived.  Survival was associ- 
ated with the development of a  level of serum antibodies of at least  1:300.  The 
authors believe that this level is an indicator of the availability of antibodies within 
the  CNS. 
Traub  (17), in experiments similar to those of Olitsky, Schlesinger, and Morgan, 
found immune serum, administered to guinea pigs that had been inoculated on the 
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first 2 days.  In analyzing the mechanism of the protective action of the immune 
serum, he showed that virus free  in the blood plasma was rapidly neutralized, but 
that virus fixed to the blood cells was more slowly inactivated.  However, no direct 
evidence of neutralization of  the virus within the nervous system was presented. 
Traub compared the potency of individual lots of immune serum, as determined by 
neutralization  tests, with their effectiveness when used therapeutically in guinea pigs. 
The results led him to indicate that neutralizstion  alone is not an adequate test of the 
therapeutic value of an antiserum in this disease. 
More recently Zichis and Shaughnessy (7) have presented convincing evidence of 
the efficacy of adequate serum therapy in the treatment of infection with the Western 
strain of equine encephalomyelitis virus.  Guinea pigs were infected by intralingual 
inoculation of the virus.  Treatment of 55 animals with hyperimmune rabbit serum 
was started when they were definitely ill.  This was usually 24 hours after the onset 
of fever.  Most of the guinea pigs were ataxlc at the time treatment was started or 
developed ataxia soon after.  Of 41 control animals given no treatment, or injected 
with normal rabbit serum, 40 died.  Thirty-seven, or 67 per cent, of the 55 treated 
animals survived.  Serum therapy was also tested in monkeys.  Of 21  animals in- 
jected intracranially  with the virus, 11 were treated with serum at the onset of fever. 
Although all developed ataxia, 5 recovered.  Of 10 control monkeys, given virus but 
no  serum,  none survived.  The  authors  emphasize  the  importance of  using large 
amounts of serum of high potency. 
A recent report by Sulkin, Zarafonetis, and Goth  (18) indicates that anesthesia 
may be a valuable adjunct to serum therapy in the treatment of virus diseases of the 
nervous system.  Using mice injected intracmnially  with the Western strain of equine 
encephalomyelitis virus in a dose sufficient to kill 80 per cent of control animals, they 
found that with serum treatment at 18 hours, 52 per cent survived.  Prolonged ether 
anesthesia  combined with  serum treatment increased the  number of  survivors to 
90 per cent. 
~EXPERIMENTAL 
Materials and Methods 
The herpes virus used in the present experiments was the HF strain used in the earlier 
studies  I-3; it had been maintained for more than 125 serial passages in Swiss mice.  The 
preparations  of the virus  used for inoculation were suspensions of infected mouse brain, 
either freshly harvested  or glycerolated for not  over  10 days.  Only Swiss mice from the 
Rochester  colony  were employed. 
The standard method of injection was the intracutaneous (and unavoidably subcutaneous) 
injection of the vires into the foot pad of 2-week-old mice, combined with rubbing the virus 
into the scarified skin of the pad.  A number of preliminary experiments on the pathogenesis 
of herpetic infection led to the selection of this mode of inoculation.  All inoculations were 
performed under light ether anesthesia. 
The serum used in the passive immunization  of mice was derived from a pool ol the serums 
of 8 hyperimmunized rabbits.  Each animal had survived injection by one of several strains 
of herpes virus and was given from 3 to 6 further immunizing injections of the HF virus in 
the form of a suspension of rabbit brain.  While no attempt was made to study in detail the 
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was definitely increased by the repeated injections.  This remark is based on assays of each 
rabbit's serum done to determine which serums were suitable for the pool. 
A total of 231 mice was employed to measure the neutralizing power of the immune serums. 
The titration tests were carried out in the following manner.  The HF virus was prepared 
as a  10 per cent suspension of mouse brain in Locke's solution.  This suspension was centri- 
fuged at slow speed for 5 minutes and the sediment discarded.  The supernatant fluid was 
designated  a  1:10  dilution  of  "virus."  Further  dilutions  (1:100,  1:1000,  1:10,000,  and 
1:100,000)  were then made.  One-half ml. or  1 ml. of immune serum was mixed with an 
equal volume of the virus dilution (1 : 10, 1 : 100, and 1 : 1000) and the mixtures were incubated 
for 2 hours at 37°C. in an air incubator.  Similar mixtures of higher dilutions of the virus 
(1 : 1000,  1:10,000 and 1 : 100,000)  and normal rabbit serum were incubated at the same time. 
At the end of the period of incubation each mixture of serum and virus was injected intra-. 
cerebrally in a dose of 0.025 ml. into each of 3 adult Swiss mice.  As may be seen in Table I, 
the result of a titration of the pooled antiserums used in the present experiments showed that, 
TABLE  I 
Neutralizing Capacity of Herpes Antiserum Prepared in Rabbits* 
Normal rabbit serum  Undiluted antiserum 
Antiserum  diluted 
1~10  1:40  1:160 
Dilution 
ofvirus ....  1:1000 1:1),(00  1:100,000  1:10  1:100  1:1000  1 100  1:100  1:100 
No. mice 
injected  3  3  3  3  3  3  3  ,~  3 
Day oi death...  4, 4,5  4, 4,6  S~,S,S  4, 4,6  6,8, S  S,S,S  6, S,S  4,6, X§  4, 5,5 
* Mixtures  of antiserum  and virus tested  by intracerebral  innoculation of mice.  See text. 
:~ S =  mouse survived for 13 days. 
§X =  mouse died of accidental trauma. 
in contrast to a control titration using normal rabbit serum, 0.025 ml. would protect against 
approximately 100 minimal, cerebral, lethal doses of the virus. 
In general, antigen-antibody titration carried out by means of the antibody dilution method 
is more accurate than one in which the antigen is diluted (20).  However, such titrations are 
not ordinarily practicable when a  virus is used as the antigen, unless it is maintained in a 
state in which it will not change in potency.  In the final assay of the p0ol of immune serums 
used in the present experiments, a titration by the antibody dilution method was made.  The 
immune serum, diluted 1 : 10, 1:40, and 1 : 160, was mixed in equal volume with a 1:100  dilution 
of the virus, the highest concentration of  the virus that was regularly neutralized by  the 
undiluted immune serum.  The mixtures were incubated and tested in mice as previously 
described.  The results are also given in Table I.  It may be seen that 2 of 3 mice were pro- 
tected by the 1:10 dilution of the immune serum. 
1.  The Pathogenesis  of Herpetic Infection in Young Mice Inoculated 
on the Foot Pad 
Preliminary  studies had shown that  young mice inoculated on the foot pad 
with HF strain of herpes virus develop paralysis of the inoculated limb, followed 
by paraplegia and finally by encephalitis that regularly cause death on the 4th 
5th,  or 6th  day  after inoculation.  As a  guide to the proposed  studies of im- 434  HERPETIC  INFECTION  IN  MICE.  IV 
munity, it  was  necessary  to  carry  out  more  detailed  investigations  of  the 
pathogenesis of these infections.  In order to study the time relationships of the 
spread of the virus to the CNS, mice were inoculated with the virus in the usual 
way and later  subjected to amputation of the inoculated foot.  Based upon 
exploratory experiments in which the techniques of inoculation and amputation 
were standardized, the following experiment was carried out. 
A group of 42 2-week-old  mice  was inoculated  on the pad of the right, hind foot.  Following 
inoculation, the feet were amputated just above the ankle joint at intervals of 2, 12, 24, 36, 48, 
60, and 72 hours.  The amputations were performed on 6 mice at each time, and the feet 
were fixed in formalin for microscopic study. 
Of the 6 mice subjected to amputation after 2 hours, 4 subsequently developed CNS dis- 
turbances, which from their inception were apparently encephalitis, and which terminated 
in death on the 5th (1 mouse), 6th, or 7th day after inoculation.  Two mice remained well. 
Of those subjected to amputation after 12 hours, 1 survived and the others died on the 5th 
(1 mouse), 6th, or 7th day.  Two of these animals had a paraplegia before the onset of en- 
cephalitis.  In all 6 of the mice from which the feet were amputed after 24 hours, the initial 
sign of disease of the nervous system was paralysis of one or both hind legs; this was foItowed 
by death on the 4th or 5th day after inoculation. 
The following interpretation of these results seems reasonable.  Amputation 
after 2 hours removed the local focus of infection and prevented invasion of the 
CNS by way of the local nerves.  However, some virus apparently escaped by 
way of the blood stream or through the lymphatics and established metastatic 
loci of infection from which it ieached the brain by other neural routes.  It has 
been shown  (3)  that,  following intranasal inoculation of herpes virus,  foci of 
infection develop regularly in  the liver and less frequently in  other viscera. 
Furthermore,  it  should be emphasized that infection of the  CNS from such 
metastatic loci does not produce the posterior paralysis characteristic of in- 
fection primary in  the foot pad.  Moreover,  the  encephalitis  resulting  from 
metastatic lesions is slower to develop. 
Amputation after 24 hours, or later,  had no effect on the course of the in- 
fection of the CNS.  All 6 animals in the 24 hour group died without delay and 
showed initially the same paralysis of the hind limbs as animals whose feet were 
not amputated after inoculation of the foot pads. 
Sections of the amputated feet to be studied  microscopically were stained 
with hematoxylin and eosin and with a modification of Shorr's stain (21).  In 
feet removed 2 hours after inoculation, the principal changes observed were 
hemorrhage and  moderate  distention  of the  tissue  spaces  by fluid.  A  few 
infiltrating cells were present.  In no instance did the sections of the amputated 
feet  give evidence that  the  inoculum had extended beyond the  ankle joint. 
In each case the amputation was seen to be 2 or 3 mm. above the distal end of 
the  tibia.  After  12 hours  there were  noted  more extensive  congestion and 
cellular  infiltration,  principally  polymorphonuclear  leucocytes,  but  also C.  A.  EVANS,  H.  B.  SLAVIN,  AND  G.  P.  BERRY  435 
lymphocytes.  No  inclusion bodies were found.  All of the feet amputated 
after 24 hours showed foci of epithelial cells containing the typical, intranuclear 
inclusions of herpes simplex.  These cells were located along the linear defects 
in the epithelium resulting from the scarification.  After longer intervals of 
time,  the sections revealed increased necrosis of the epithelium and diffuse, 
severe inflammation of the foot pad. 
The significant point emerging from these observations is that, between 12 
and 24 hours after inoculation, the primary virus infection reached maturity in 
epithelial cells and virus began to pass up the local nerves towards the CNS. 
Accordingly, it was decided, in the studies of immunity, to perform the amputa- 
tion after an interval of 24 hours in order to eliminate the primary focus and yet 
not interfere with the progress of direct infection of the CNS from the foot 
pad. 
2.  Passive Immunity to Herpetic Infection  in Mice with Special Reference to the 
CNS.  Peripheral Inoculation of the Virus 
In the immunological studies designed to explore the effect of specific anti- 
bodies on the invasion of the CNS of mice by herpes virus, 2 sets of experiments 
were carried out.  In the first set (A), the effect of immune serum was investi- 
gated without the elimination of the primary focus of infection.  In the second 
set (B), the primary focus was eliminated by amputation of the inoculated foot 
and the immune serum was injected at various intervals of time thereafter. 
A.  Passive Immunity in Mice with the Primary Lesion lntact.--Preliminary 
experiments involving 20 young mice showed that the largest dose of serum that 
could be administered at one injection to 2-week-old mice was 0.5  ml.  This 
dose of the antiserum was effective in protecting the young mice from detectable 
infection by the HF virus if the serum was given before the inoculation of the 
foot pad.  An experiment was next set up to discover the effect of the immune 
serum at various intervals of time after the inoculation of the virus, the primary 
herpetic lesion on the foot being left intact. 
Forty-eight 2-week-old mice were inoculated with the HF virus on the pad of the right, 
hind foot.  They were then divided into 8 groups of 6 mice each.  The mice in each group 
were injected intraperitoneally with 0.5 ml. of normal (control), or immune, serum according 
to  the following schedule.  One  group  was given normal rabbit serum immediately after 
the inoculation of the virus and a second group received immune serum at the same time.  The 
mice in the remaining 6 groups were given immune serum at intervals of 12 hours, the last 
group being injected 72 hours after inoculation of the virus.  The 6 mice that received normal 
serum were selected from 6 litters; those in each of the other groups were from 2 or 3 liters. 
The normal serum exerted no protective effect and all of the control mice died 
on the 4th or 5th day.  The immune serum given at zero time completely 
protected 5 of the 6 mice; 1 died on the 6th day.  At 12 hours,  the immune 
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the 4th day and died on the 5th, 6th, or  7th day.  Three showed no paralysis 
and survived.  One of the mice given serum at 24 hours died of an accidental 
cause.  Four of the remaining 5 were paralyzed on the 4th day and died on the 
5th or 6th day.  The fifth mouse developed, on the 6th day, a  partial mono- 
plegia which persisted to the end of the experiment, 23 days after inoculation. 
Immune serum injected at 36 and 48 hours seemed to retard the infection.  In 
each case 5 of the 6 mice died between the 4th and the 7th days.  All mice that 
received immune serum at 60 hours and at 72 hours died. 
The results just described show dearly that immune serum exerts a definite 
effect upon herpetic infection of the type under study and that the effectiveness 
of antiserum decreases progressively as the time between the inoculation of the 
virus and the injection of the immune serum is increased. 
The local lesions of the inoculated foot pads were examined grossly.  The 
mice given the immune serum at zero time showed no evidence of herpetic 
infection of the feet, whereas those injected with immune serum at 12 hours had 
the typical encrusted lesions of an herpetic infection of the skin.  Apparently, 
the immune serum given at zero time had neutralized the virus before it could 
enter susceptible epithelial ceils, whereas the serum given at 12 hours did not 
prevent the infection of epithelial cells.  In many animals it presumably acted 
to prevent the spread of the virus from the initial cutaneous focus to the nervous 
system.  In view of the preceding studies on pathogenesis, it seemed probable 
CHARTS 1 to 5.  Therapeutic  effect of immune rabbit serum on herpetic infection of the 
nervous system of 2-week-old mice. 
Each horizontal line represents 1 mouse.  The vertical lines mark the lapse of time after 
inoculation of the virus.  All of the animals were inoculated with herpes virus on the pad of 
the right,  hind foot.  Twenty-four hours later the inoculated  feet were amputated.  The 
control group of animals, shown in Chart 1, was subjected to inoculation and amputation but 
received no antiserum.  The mice'in  the control group were litter mates of those treated with 
antiserum.  The litter from which individual animals were obtained  is indicated in each 
chart.  Charts 2 to 5 show the effect of treatment with specific antiserum, given intmperi- 
toneally, at various intervals after inoculation of the virus.  Thus, in Chart 2, serum was 
administered 24 hours after introduction of the virus and 1 hour after the infected feet had 
been amputated; in Chart 3, serum was given 6 hours after the feet had been amputated and 
30 hours after inoculation of the virus. 
Paralysis involving 1 or both hind quarters is shown by shading of the region involved 
Encephalitis (hyperirritability,  lethargy, ruffling, ataxia) is indicated by shading the area of 
the head.  Shading of the entire mouse means that the mouse was found dead. 
It may be noted in Chart 1 that the first sign of illness in all the control animals was either 
paralysis of the leg from which the foot had been amputed, or a posterior paraplegia.  This 
is interpreted to indicate that, at the time the foot was amputated, the virus was in the nerves 
leading from the foot to the spinal cord.  As is shown in Charts 2 to 5 serum therapy retarded 
the progress of the infection of the nervous system in many mice, while in others it completely 
arrested  the infection. 
On the basis of delayed paralysis and prolonged survival, the data shown in all 5 charts are 
presented in summary and analyzed statistically  in Table II. C. A. EVANS, H. B. SLAVIN, AND G. P.  BERRY  437 
that the protective action of antiserum, given 24 hours or later after the intro- 
duction of the virus, must be the result, at  least in part, of the action of the 
antibodies on the  virus  within  the  nervous  system.  To determine  whether 
this was actually the case, a final experiment was carried out. 
No  5¢rum 
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B.  Passive Immunity in Mice with the Elimination  of the Primary Lesion.-- 
A total of 80 2-week-old mice from 13 litters was used to test the effect of the immune serum 
on herpetic infections of the nervous system induced by peripheral inoculation of the virus 
but uncomplicated by the presence of the primary lesion.  All of'the mice were inoculated 
Serum at 24 hours 
0~  0  I  ~,  3  A./~P.M.AM.P.M~A./~P.MAN.  RM. 
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.on the foot pad with HF virus.  Twenty-four hours later the inoculated feet were amputated 
well above the ankle joint. 
Fifteen of the mice from 5 small litters were given no further treatment.  The remaining 
65 mice were from 8 litters of 8 or 9 mice each.  Two mice from each of these 8 litters were 
given no further treatment and served as litter mate controls of treated mice.  Immune serum 
was injected intraperitoneally in a dose of 0.5 ml. into the remaining 51 mice from 8 litters, 
according to the following schedule. 
1.  Within 1 hour after amputation (24 hours after inoculation of the virus)--2 mice from 
each of ? litters and 1 mouse from the additional litter. 
~0:1  2. 
Serum  at  30  hours 
5  e  [  T  819  io  i i  t2  t~  H  15 
"~  IA./~4P.M.A.M.P.M  AM. P.M.A.M.P.M  l 
Cm~T  3 
2.  Six hours after amputation (30 hours after inoculation of the virus)--2 mice from each 
of 4  litters. 
3.  Twelve hours after amputation (36 hours after inoculation of the virus)--2 mice from 
each of 8 litters. 
h  4.  Twenty-four hours after amputation (48 hours after inoculation of the virus)--2 mice 
from each of 2 litters, and 3 mice from each of 2 litters. 
Details of the distribution of treated mice in various litters are shown in Charts 1 to 5. 
The mice were examined regularly in the morning and in the evening.  In most instances 
therewas an interval of 10 hours between the two inspections.  The interval was never less 
than 8 hours, or longer than 12 hours.  Survivors were discarded after 15 days. 
The following data were  considered significant in interpreting  the results of 
the experiment:  (1)  the time at which definite paralysis first appeared;  (2) the 440  HERPETIC  INFECTION  IN  MICE.  IV 
4 
Serum o~r 36 hour5 
5  -6  I  T  ~  9  IO  II  12  I~  14  15 
CH~T  4 
time of death; (3) the number of mice that  survived.  Inspection of Charts I 
to 5 shows that, in general, mice treated with immune serum became paralyzed 
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striking in the case of mice treated at 24 hours and is progressively less marked 
as treatment was delayed. 
The significance of the findings is revealed by statistical analysis, using the 
x ~ method (22).  In Table II, data obtained by a  comparison of treated mice 
with  their litter mate controls are presented.  It is ~pparent that the delay 
in paralysis and the prolongation of life of treated animals is highly significant 
:in groups treated at 24, 30, and 36 hours.  The evidence that serum given at 
24 hours caused a  delayed paralysis and a  prolonged survival of mice is over- 
Serum at 48 houre 
o  i  2  s'  4  ~M.~p.M.,~.~p.~  r  8  9~mo  .  12  I~  f4  15 
AM. P.M,  A.M.P.M. 
5" 
Ca~T 5 
whelming.  Such results could be expected on the basis of chance not once in 
100,000  times.  The results, when serum was given at 30 or at 36 hours, are 
significant in that the difference between treated and untreated animals could 
not be expected to occur as a result of chance one in 1,000 times.  It should be 
emphasized that the data in Table II are based on a comparison of each treated 
mouse with 2 litter mate controls but that the same 2 litter mate controls are 
compared with more than 1 treated animal.  Inasmuch as 2 mice in each of the 
8 litters served as untreated controls, there was a total of 16 in the control group. 442  HERPETIC INFECTION IN MICE.  IV 
According to their origin from various litters, the mice treated at various time 
intervals are compared with all or a part of this same group of control animals. 
It will be recalled that  15 mice from 5  small litters were inoculated and 
subjected to amputation.  None of their litter mates was treated with serum+ 
TABLE  II 
Tkerapeutic Effect of Immune Serum on Herpetic Infection of tke Nervous System of g-Week-OM 
Mice.*  Comparison of Treated Mice with Their latter Mate Controls on the Basis of Ddayed' 
Paralysis and Prolonged Survival~ 
A.  Serum injected 24 hrs. after in- 
oculation of virus 
Probability  that  difference 
from controls is due to chance 
B.  Serum injected 30 hrs. after in- 
oculation of virus 
Probability  that  difference 
from controls is due to chance 
C.  Serum injected 36 hrs..after in- 
oculation of virus 
Probability  that  difference 
from controls is due to chance 
D. Serum injected 48 hrs. after in- 
oculation of virus 
Probability  that  difference 
from controls is due to chance 
No. litter  No. mice 
mate  treated 
controls  with  Became  paralyzed 
serum  later than controls 
16  14  13 
1 in more than 1 
million (x  2 -- 
26.24) 
8  8  7 
1  in  more  than 
1, .000 (x  ~ = 
12.44) 
No. treated mice that 
16  16  9 
1 in  more  than 
1,000  (x  ~  = 
12.52) 
8  10  3 
1  in  10  (x  •  ffi 
2.9) 
Lived longer 
than controls 
11 
1  in  more  than 
!  lOO,OOO  (x'  = 
19.85) 
t 
i  7 
1  in  more  than 
1,000  (x'  ffi 
12.44) 
1  in  more  than 
1,000  (x  ~  = 
12.52) 
1  in  50  (x'  - 
s.s4) 
* All animals inoculated on right, hind foot pads with the virus.  Feet a~nputated 24 
hours later.  Treated mice given immune serum intraperitoneaUy. 
Comparison of treated mice with their 16 litter mate controls is also shown in Charts 
lto5. 
Therefore, they are not represented in Charts 1 to 5 and Table II,  in which a 
comparison of serum-treated mice with untreated litter mates is presented. 
By grouping together all mice treated at a given time and comparing them with 
all untreated mice irrespective of litter, it is possible to include these 15 mice in 
the calculations.  In Table III, the results of an analysis of this method are 
presented.  It was found convenient to compare the treated mice with  the C. A. EVANS~  H. B. SLAV'IN,  AND  G. P. BERRY  443 
control group on the basis of the number of mice paralyzed at 4 days, and the 
number dead at 5  days. 
The data in Table III show clearly that many cf the treated mice and few of 
the untreated controls were free from paralysis after the 4th day.  Similarly, 
nearly all control mice died on or before the 5th day,  but many of the treated 
TABLE III 
Therapeutic Effect of Immune Serum on Herpetic Infection of the Nervous System of 2-Week-Old 
Mice.*  Comparison of Treated Mice witk All Control Animals Irrespective of Litter on the 
Basis of Paralysis by 4tk Day and Death by 5tk Day after Inoculation of the Virus~ 
I. Paralysis by 4tk Day 
Mice treated with serum at 
24 hrs  ........................ 
30 hrs  ........................ 
36 hrs  ........................ 
48 hrs  ........................ 
Control mice .................... 
No.p~a~d 
2 
1 
8 
6 
28 
No. not 
paralyzed 
12 
7 
8 
4 
3 
Probability that 
difference from 
controls is due to 
chance 
(x') 
1 in 1 million  25.1 
1 in 100,000  20.1 
1 in 500  9.6 
1 in 25  4.3 
II.  Deaths by 5tk Day 
Probability that 
No. dead  No. not dead  difference from 
controls  is due to  (x2) 
chance 
Mice treated with serum at 
24 hrs  ........................ 
30 hrs  ....................... 
36 hrs ....................... 
48hrs  ....................... 
Control mice ................... 
7 
2 
8 
6 
29 
1 in  1,000  11.4 
1 in  50,000  18.3 
1in  2,000  12.0 
1 in  100  7.3 
* All animals inoculated  on right, hind foot pad with the virus.  Feet amputated 24 hours 
later. Treated mice given immune serum intraperitoneally. 
In addition to 16 litter mates, the control animals in this table include 15 mice from 5 
litters in which none was treated with antiserum. 
mice lived beyond this time.  The difference between treated and control mice 
is most striking in the groups given antiserum at 24, 30, or 36 hours.  The data 
in Table III, because they include a  larger number of control animals than 
those in Table II, raise the x 2 value of observed differences to the point where 
the beneficial effects of treatment, even as late as 48 hours after inoculation of 
the virus, may be significant. 
Up to this point, results have been analyzed in terms of a retardation of the 444  HERPETIC  INFECTION  IN  MICE.  IV 
herpetic  infection  of  the  nervous  system  (delayed  paralysis  and  prolonged 
survival) as a result of treatment with immune serum.  It is readily seen from 
Charts  1 to 5 that in an appreciable number of treated mice the infection was 
not  only retarded,  it  was completely arrested; the mice survived.  In Table 
IV,  the  numbers  of surviving  mice in  the  several  groups are  tabulated.  A 
total of 11 of the 48 mice given serum treatment survived,  whereas none of the 
31  control mice remained  alive.  The  difference  is  shown  to be  statistically 
significant.  The numbers of mice employed were not sufficient to justify an 
TABLE IV 
Tlterapeuti,  Effect of Immune Serum on Herpet~ Infection of the Nervous System of g-Week-Old 
Mice as Indicated  by Survival  of Treated Animals 
Mice treated with serum at 
24 hrs  .... 
30 hrs.. 
36 hrs  ..... 
48 hrs  ..... 
No.  mice 
treated 
14 
8 
16 
10 
No. survivors 
at  15 days 
Probabi~tythat 
difference from 
controlsis due to 
chance 
Totals, 24-48 hrs  .....  48  11  1 in 250  (x  2)  8., 
Controls* (no serum).  31  0 
* As in Table III, these include all control mice, both litter mates and non-litter  mates of 
treated animals. 
attempt to evaluate  the efficacy of treatment  as a  life-saving measure  at  the 
different time intervals. 
DISCUSSION 
Immune serum may protect young mice against herpetic infection in three 
distinct  ways.  First,  immune  serum administered  before or very soon after 
the inoculation of the virus prevents even a  relatively large dose of the virus 
from  infecting  epithelial  cells  at  the  site  of  inoculation.  No  visible  lesion 
develops beyond that resulting from trauma.  Second, immune serum injected 
several hours after the inoculation of the virus (12 hours in the present study) 
does not prevent  a  local lesion  from developing.  Despite  this,  the  virus  is 
prevented,  in many of the  animals,  from invading  the nervous system suffi- 
ciently to cause symptoms.  Probably, neutralization  of the virus takes place 
principally after  the virus leaves infected epithelial ceils  and before it enters 
nerve  fibers.  Thus,  while  infection  of the  epithelial  cells  occurs,  significant C.  A.  EVANS,  H.  B.  SLAVIN,  AND  G.  P.  BER.RY  445 
involvement of the  nervous system is  prevented in  many animals.  Third, 
immune serum exerts a protective action by combatting the activity of the virus 
within the nervous system.  In order to demonstrate the action of antibodies 
on  the  virus within  the nervous system,  it was  necessary to eliminate  the 
second type of protective activity.  This was achieved by the amputation  of 
the site of peripheral infection, the foot. 
It is worthy of emphasis that, in all  the control animals whose feet were 
amputated at the appropriate time, the first sign of neurological disturbance was 
a  posterior monoplegia or paraplegia.  It is difficult to interpret this in any 
other way than that, at the time the foot was amputated, the virus was in the 
nerves leading from the foot to the central nervous system if not already in the 
spinal cord.  It follows, therefore, that the beneficial effect of serum therapy, 
under  the conditions of this  experiment, was  an  effect on  the  virus in  the 
nervous system.  It is almost inconceivable that antibodies could reach virus 
present in axis cylinders of the sciatic nerve before it has attained cell bodies. 
It is more likely that they exerted their effect within the central nervous system. 
Metastatic lesions in the viscera were probably present in some mice, but it is 
unlikely that they could have been responsible for the focal paralyses so regu- 
larly observed.  Therefore, their presence does not interfere with the signifi- 
cance of the effect of serum in delaying or preventing paralysis. 
The question arises whether normal rabbit serum could have exerted a non- 
specific  protective  effect.  This  seems  unlikely.  Normal  serum  has  been 
shown to have no effect in neutralization tests using small amounts of herpes 
virus, and, in the preliminary experiments in which mice were inoculated on the 
foot pad and given normal serum intraperitoneally, infection progressed at the 
same rate as in untreated mice. 
It is of interest to speculate on the relative efficacy of humoral antibodies in 
combatting virus infections of the nervous system as compared with similar 
activity of antibodies in opposing virus infections in other organs, such as the 
liver or skin.  The existence of a barrier between the blood stream and brain 
tissue is well established (23) on the basis of experiments on the diffusion of dyes 
and  other  substances.  It  has  been  postulated  (24)  that  the  "blood-brain 
barrier" acts to interfere with the passage of antibodies into the nervous system, 
thus limiting  the effectiveness of circulating antibodies in  combatting virus 
infections of these tissues, the implication being that this situation is peculiar 
to the central nervous system.  The experiments described in the present paper 
show that  antibodies can be effective in spite of the  "blood-brain  barrier" 
if given during the first quarter or third of the incubation period.  This is 
roughly comparable to  the  period  during  which  effective serum  therapy  is 
possible in measles. 
Studies on herpetic infections of man (25-29) have an important bearing on 
the question of the relative efficacy of antibodies in controlling virus infections 446  HERPETIC  INFECTION  IN"  MICE.  IV 
of nervous and non-nervous tissues.  Those human beings whose serum con- 
tains a relatively high titer of neutralizing antibodies for herpes virus may be 
susceptible  to  recurrent  attacks  of herpes  simplex.  There  is  no  apparent 
correlation between the presence of such antibodies and resistance to this type 
of cutaneous infection.  From the work of Gildemeister and Ahlfeld (29)  and 
from other studies (30), it seems probable that, in many cases, human beings 
susceptible to recurrent attacks of herpes simplex possess specific antibodies in 
a  concentration approximating  that  obtained in  the  present  experiments in 
mice.  These facts suggest that humoral antibodies may be no more effective 
in preventing the spread of herpes virus from one epithelial cell to another in 
human skin than in preventing the spread of this same virus from one nerve cell 
to another in the brain of a young mouse.  It seems possible that the "blood- 
brain barrier" in young mice exerts no greater restraint upon humoral anti- 
bodies than is imposed by the natural barriers between the blood and epidermis 
in man. 
Until more information of a quantitative nature is available, it would seem 
unwise to assume that  the "blood-brain barrier" makes the central nervous 
system  peculiarly  susceptible  to  virus  infections  by  imposing  an  unusual 
obstruction  to  the  passage  of  antibodies.  It  seems  not  unlikely  that  the 
"blood-epidermis" barrier may prove to be as formidable as the "blood-brain 
barrier." 
SUMMARY 
Two-week-old mice inoculated with herpes virus on the pad of a hind foot 
regularly developed paralysis of the infected limb followed by paraplegia and 
encephalitis terminating fatally 5 or 6 days after inoculation. 
Hyperimmune rabbit  serum given intraperitoneally at the time virus was 
inoculated on the foot pad prevented the formation of an herpetic lesion of the 
foot pad.  When the antiserum was g!ven 12 hours after inoculation of the 
virus, a typical infection of the epithelium of the foot pad developed, but the 
virus was prevented from causing obvious signs  of infection Gf the nervous 
system in many of the animals. 
Amputation of the foot 2 hours after the inoculation of the virus prevented 
the paralysis of the hind leg.  Some of the mice died of a delayed encephalitis. 
Amputation of the foot at 24 hours neither prevented nor delayed the sequence 
of paralysis of the hind leg, encephalitis, and death. 
In  order to study immune  serum  therapy of an infection of the  nervous 
system  uncomplicated  by  a  peripheral  focus  of  infection  or  by  traumatic 
disturbance of the cer~tral nervous system, 2-week-old mice were inoculated on 
the foot pad, the infected feet were amputated 24 hours later, and the immune 
serum was administered at varying intervals thereafter. 
Using litter mate controls and statistically significant numbers of mice, it C. A. EVANS,  H. B.  SLAVIN~  AND  G. P. BERRY  447 
was shown that hyperimmune rabbit serum, administered during the first one- 
third of the incubation period, retards and, in some cases, arrests the progress 
of herpetic infection within the nervous system. 
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